These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 31786528)

  • 1. Relationship Between Platelet Reactivity and Periprocedural Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention.
    Choi SY; Kim MH; Hyun KY; Lee MS
    J Invasive Cardiol; 2019 Dec; 31(12):E369-E375. PubMed ID: 31786528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Kwon O; Ahn JH; Koh JS; Park Y; Hwang SJ; Tantry US; Gurbel PA; Hwang JY; Jeong YH
    Eur Heart J; 2024 Jul; 45(25):2217-2231. PubMed ID: 38804262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium.
    Jeon KH; Jeong YH; Chae IH; Kim BK; Joo HJ; Chang K; Park Y; Song YB; Ahn SG; Lee SY; Cho JR; Her AY; Kim HS; Kim MH; Lim DS; Shin ES; Suh JW;
    Cardiovasc Diabetol; 2023 Sep; 22(1):245. PubMed ID: 37679760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Age- and Body Mass Index-Stratified High On-Treatment Platelet Reactivity With Coronary Intervention Outcomes in East Asian Patients.
    Cha JJ; Lee SJ; Park JH; Hong SJ; Ahn TH; Chang K; Park Y; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Jeong YH; Kim HS; Kim MH; Shin ES; Kim BK; Lim DS
    J Am Heart Assoc; 2024 May; 13(9):e031819. PubMed ID: 38639339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention.
    Ricottini E; Gatto L; Nusca A; Melfi R; Mangiacapra F; Albano M; Cavallaro C; Pozzilli P; Di Sciascio G; Prati F; Ussia GP; Grigioni F
    Clin Nutr ESPEN; 2023 Dec; 58():104-110. PubMed ID: 38056992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.
    Stähli BE; Gebhard C; Duchatelle V; Cournoyer D; Petroni T; Tanguay JF; Robb S; Mann J; Guertin MC; Wright RS; L L'Allier P; Tardif JC
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation modifies the platelet reactivity among thrombocytopenia patients undergoing percutaneous coronary intervention.
    Yan K; Li J; Li Y; Zhu P; Tang X; Yuan D; Yang Y; Gao R; Yuan J; Zhao X
    Platelets; 2024 Dec; 35(1):2327835. PubMed ID: 38655673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions - is there an association?
    Stipinovic M; Percin L; Radonic V; Jerkic H; Jurin I; Letilovic T
    Medicine (Baltimore); 2019 Oct; 98(43):e16989. PubMed ID: 31651833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality After Procedural or Spontaneous Myocardial Infarction.
    Spirito A; Sartori S; Koshy AN; Feng Y; Vogel B; Baber U; Sweeny J; Khera S; Kini AS; Windecker S; Dangas G; Sharma SK; Mehran R
    J Am Coll Cardiol; 2024 Jul; 84(5):467-477. PubMed ID: 39048279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate Platelet Inhibition Strategy for Comatose Out-of-Hospital Cardiac Arrest Survivors Undergoing Percutaneous Coronary Intervention and Mild Therapeutic Hypothermia.
    Kordis P; Berden J; Mikuz U; Noc M
    J Clin Med; 2024 Apr; 13(7):. PubMed ID: 38610886
    [No Abstract]   [Full Text] [Related]  

  • 11. Different association of atherogenic index of plasma with the risk of high platelet reactivity according to the presentation of acute myocardial infarction.
    Won KB; Kim HJ; Cho JH; Lee SY; Her AY; Kim BK; Joo HJ; Park Y; Chang K; Song YB; Ahn SG; Suh JW; Cho JR; Kim HS; Kim MH; Lim DS; Kim SW; Jeong YH; Shin ES
    Sci Rep; 2024 May; 14(1):10894. PubMed ID: 38740817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters.
    Gorog DA
    Eur Heart J; 2024 Jul; 45(25):2232-2234. PubMed ID: 38804269
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of simple inflammatory parameters in predicting the severity of coronary artery disease.
    Aydın C; Uyan U; Karadeniz M; Demirkıran A
    Rev Assoc Med Bras (1992); 2023; 69(11):e20230518. PubMed ID: 37820166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet Pretreatment Before Angiography With Anticipated or Planned Percutaneous Coronary Intervention in Stable Ischemic Heart Disease.
    Welsh RC
    Can J Cardiol; 2024 Jan; 40(1):40-42. PubMed ID: 38013063
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cardiac rehabilitation on inflammatory biomarkers in unstable ischemic heart disease patients following percutaneous coronary intervention: a randomized controlled study.
    Awada M; Sanaei S; Jameie M; Rahnamoun Z
    Coron Artery Dis; 2024 Jan; 35(1):8-13. PubMed ID: 37990628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another Piece of the Complex Puzzle: Outcomes of Percutaneous Coronary Intervention in Older Adults.
    Davies RE; Hall AB; Chen MA
    J Am Heart Assoc; 2023 Oct; 12(19):e031827. PubMed ID: 37776215
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the efficacy of
    Mitchell DL; McGuire LS; Khalid SI; Alaraj A
    Interv Neuroradiol; 2024 Jan; ():15910199231224008. PubMed ID: 38186294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the efficacy of
    Mitchell DL; McGuire LS; Khalid SI; Alaraj A
    Interv Neuroradiol; 2024 Jan; ():15910199231225716. PubMed ID: 38192126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study.
    Hammoudeh AJ; Alhaddad IA; Khader Y; Tabbalat R; Al-Mousa E; Saleh A; Jarrah M; Nammas A; Izraiq M
    J Saudi Heart Assoc; 2017 Jul; 29(3):195-202. PubMed ID: 28652673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implication of Platelet Reactivity According to Procedural Complexity After PCI: Subanalysis of PTRG-DES Consortium.
    Jin X; Jeong YH; Lee KM; Yun SC; Kim BK; Joo HJ; Chang K; Park YW; Song YB; Ahn SG; Suh JW; Lee SY; Cho JR; Her AY; Kim HS; Lim DS; Shin ES; Kim MH;
    JACC Asia; 2024 Mar; 4(3):185-198. PubMed ID: 38463677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.